Anti-cancer therapies, which are becoming more and more effective, nevertheless produce serious adverse effects. Some 80% of patients suffer from skin side effects1, which sometimes push them to interrupt their treatment. Already committed for ten years alongside these patients, La Roche-Posay is now going further, launching Fight With Care.
At the same time accelerator of scientific research, training tool for professionals, and vector of support for patients and associations, Fight With Care is placed on the field of the concrete, the useful.
Its ambitions by 2025: to raise awareness among 1 billion people worldwide about the side effects of cancer treatments, train 1 million people in supportive care to relieve them, and support 100,000 patients in their fight against the disease.
Dry skin, itching, burning, inflammation around the nail are all side effects frequently caused by cancer therapies. Heavy with physical and psychological impacts, these changes are often considered by patients as inevitable. Some go so far as to suspend their treatment so that they no longer have to undergo them, thus compromising their chances of recovery.
However, targeted dermo-cosmetic treatments exist and can help relieve patients... provided that they are informed. However, in 2018, 84% of cancer patients were not referred to any dermatologist2. This situation is all the more damaging as alleviating treatment-related skin problems is essential: 80% of patients consider supportive care as important as the main treatments3.
Based on this observation, La Roche-Posay, already engaged for more than ten years alongside cancer patients, has decided to intensify its action, by launching the Fight With Care program.
"La Roche-Posay, together with dermatologists from all over the world, has been working with cancer patients for more than 10 years. But we still hear patients say, "If I had known there were dermatological solutions, it would have changed my life!" That's why today we're going further with Fight with Care. It seems essential to us to raise awareness of these solutions, capable of providing essential relief to patients,"says Laetitia Toupet, President of La Roche-Posay International.
The Fight With Care program is divided into four pillars and many concrete actions.
To help advance knowledge on this major public health issue, La Roche-Posay is expanding its historic collaboration with the most recognized experts in their field, and is partnering with the MASCC (Multinational Association of Supportive Care in Cancer) and AFSOS (Association francophone pour les soins oncologiques de support). La Roche-Posay will thus contribute by December 2021 to the development of the first international consensus to publish recommendations for the treatment of skin side effects related to cancer treatments. The work of this international committee of experts, led by an important network of partners within the medical world, will aim to inform health professionals, through practical advice and a global approach to skin toxicities.
To usefully support patients where they are (hospital, pharmacy, home...), Fight with Care offers a set of concrete actions to accompany them in their daily lives. The brand is launching a new internet platform (mapeaupendantuncancer.fr) to raise awareness and support patients and a new patient guide offering expert advice and testimonials to support patients but also allow their entourage to provide useful advice (see box below).
To offer patients clearer information, La Roche-Posay has also decided to add a specific logo to the back of 14 of its products. This new logo will make it possible to identify the products tested, under dermatological control, by cancer patients, and having allowed them to improve their quality of life.
The modalities of patient care are evolving: hospitalizations at home, or oral chemotherapy delivered in pharmacies, are becoming more and more frequent. The role of the pharmacist is therefore becoming increasingly central to the health journey of these patients.
Thus, in France, pharmacists have been entrusted, since January 1, 2021, with the responsibility of offering pharmaceutical interviews to patients undergoing oral chemotherapy (CTO). But today only 6% of breast cancer patients seek information from their pharmacist. And among the latter, 77% admit that they do not know how to answer all their questions4 .
This is why La Roche-Posay, with the support of AFSOS, offers two new training courses (online and/or face-to-face) for pharmacists and validated by a committee of experts. They will make it possible to train in the different types of cancer, the care pathways, the anti-cancer therapies and their adverse effects. Pharmacists will also have advice on how to conduct a pharmaceutical interview in oncology, in order to better meet patients' expectations.
Support patient associations
Patient associations are asserting themselves as indispensable relays in the fight against cancer, on a daily basis. This is why Fight With Care also aims to support, through donations, a number of associative projects.
La Roche-Posay is already involved alongside RoseUp Association 5 in France. This partnership has helped fund:
• The digitalization of Rose houses, which welcome patients to provide them with advice and support.
• The creation of a film presenting the association and its 10 years of action.
• Co-constructing a simple and effective method to teach women to take care of themselves and their skin during cancer.
Fight With Care, at the heart of a more global commitment against cancer
The latest addition to La Roche-Posay's cancer action programs, Fight With Care is part of the brand's broader commitment. Thus, La Roche-Posay is carrying out, in parallel, two other major actions:
"Save Your Skin": a program dedicated to the prevention of skin cancers. For more than 20 years, the brand has performed more than 400,000 free melanoma screenings with dermatologists in 35 countries. By 2025, it plans to increase this number to 500,000.
"A Better Life For Children With Cancer": this onco-pediatric support program was launched in 2019 by the La Roche-Posay Foundation and its partner Childhood Cancer International. Created with a multidisciplinary scientific committee and families, it aims to improve the quality of life and break the isolation of children with cancer and their loved ones.
"With Fight With Care, our commitment is gaining new momentum. By 2025, we aim to inform nearly 1 billion people about the problems related to skin toxicity of cancer treatments; to train 1 million of them in supportive care to relieve them, and to directly support 100,000 in their fight against the disease. Cancer can affect us all. Directly or indirectly. Beyond the numbers, Fight with Care ultimately aims at a single objective: to be useful and improve the daily lives of as many women and men as possible around the world,"says Laetitia Toupet, President of La Roche-Posay International.
- 80% of patients suffer from side effects on the skin during cancer treatments
- 93% of La Roche-Posay users find their comfort and well-being improved
- 80% of patients believe that supportive care is as important as treatment
- 9 scientific studies and 12 publications dedicated to the effects of cancer treatments were conducted by La Roche-Posay
- More than 10 years of brand commitment
1. Charles C, et al. Impact of cutaneous toxicity associated with targeted therapies on quality of life. Results of a longitudinal exploratory study. Bulletin du Cancer. March 2013;100(3):213-22.
2. Association of Community Cancer Centers / accc-cancer.org Addressing dermatologic adverse events associated with oncologic therapies by Stephanie Kao, ba, and adam friedman, MD December 2018
3. Afsos / Odoxa study January 2020
4. Survey conducted among women with breast cancer by the Rose up association. Collection of testimonies conducted between July 1 and August 31, 2020 with 135 women.
5. RoseUp is an association of general interest founded by patients and relatives of patients. She accompanies, informs and defends the rights of women affected by cancer. https://www.rose-up.fr/